CID 163280903

Pebezertinib

Structural Information

Molecular Formula
C24H19F4N7O
SMILES
CN1C=C(C=N1)NC2=NC=C(C(=N2)NC3=C(C=CC(=C3)NC(=O)C=C)F)C4=CC=C(C=C4)C(F)(F)F
InChI
InChI=1S/C24H19F4N7O/c1-3-21(36)31-16-8-9-19(25)20(10-16)33-22-18(14-4-6-15(7-5-14)24(26,27)28)12-29-23(34-22)32-17-11-30-35(2)13-17/h3-13H,1H2,2H3,(H,31,36)(H2,29,32,33,34)
InChIKey
XIMJCWSFLXXQMZ-UHFFFAOYSA-N
Compound name
N-[4-fluoro-3-[[2-[(1-methylpyrazol-4-yl)amino]-5-[4-(trifluoromethyl)phenyl]pyrimidin-4-yl]amino]phenyl]prop-2-enamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

2
References

14
Patents

497.15872 Da
Monoisotopic Mass

4.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 498.16600 204.8
[M+Na]+ 520.14794 212.8
[M+NH4]+ 515.19254 205.7
[M+K]+ 536.12188 209.6
[M-H]- 496.15144 204.4
[M+Na-2H]- 518.13339 210.7
[M]+ 497.15817 205.2
[M]- 497.15927 205.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe